AAAAAA
Results: 1-25/34
Authors:
Adachi, JD
Citation: Jd. Adachi, Corticosteroid-induced osteoporosis, INT J F W M, 46(4), 2001, pp. 190-205
Authors:
Woo, T
Adachi, JD
Citation: T. Woo et Jd. Adachi, Role of bisphosphonates and calcitonin in the prevention and treatment of osteoporosis, BEST PR R C, 15(3), 2001, pp. 469-481
Authors:
Papaioannou, A
Ferko, NC
Adachi, JD
Citation: A. Papaioannou et al., All patients with inflammatory bowel disease should have bone density assessment: Pro, INFLAMM B D, 7(2), 2001, pp. 158-162
Authors:
Wiktorowicz, ME
Goeree, R
Papaioannou, A
Adachi, JD
Papadimitropoulos, E
Citation: Me. Wiktorowicz et al., Economic implications of hip fracture: Health service use, institutional care and cost in Canada, OSTEOPOR IN, 12(4), 2001, pp. 271-278
Authors:
Cranney, A
Guyatt, G
Krolicki, N
Welch, V
Griffith, L
Adachi, JD
Shea, B
Tugwell, P
Wells, G
Citation: A. Cranney et al., A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis, OSTEOPOR IN, 12(2), 2001, pp. 140-151
Authors:
Tosteson, ANA
Jonsson, B
Grima, DT
O'Brien, BJ
Black, DM
Adachi, JD
Citation: Ana. Tosteson et al., Challenges for model-based economic evaluations of postmenopausal osteoporosis interventions, OSTEOPOR IN, 12(10), 2001, pp. 849-857
Authors:
Papaioannou, A
Adachi, JD
Parkinson, W
Stephenson, G
Bedard, M
Citation: A. Papaioannou et al., Lengthy hospitalization associated with vertebral fractures despite control for comorbid conditions, OSTEOPOR IN, 12(10), 2001, pp. 870-874
Authors:
Prior, JC
Kirkland, SA
Joseph, L
Kreiger, N
Murray, TM
Hanley, DA
Adachi, JD
Vigna, YM
Berger, C
Blondeau, L
Jackson, SA
Tenenhouse, A
Citation: Jc. Prior et al., Oval contraceptive use and bone mineral density in premenopausal women: cross-sectional, population-based data from the Canadian Multicentre Osteoporosis Study, CAN MED A J, 165(8), 2001, pp. 1023-1029
Authors:
Adachi, JD
Papaioannou, A
Citation: Jd. Adachi et A. Papaioannou, Corticosteroid-induced osteoporosis - Detection and management, DRUG SAFETY, 24(8), 2001, pp. 607-624
Authors:
Arlen, DJ
Lambert, K
Ioannidis, G
Adachi, JD
Citation: Dj. Arlen et al., Treatment of established bone loss after renal transplantation with etidronate, TRANSPLANT, 71(5), 2001, pp. 669-673
Authors:
Ioannidis, G
Gordon, M
Adachi, JD
Citation: G. Ioannidis et al., Quality of life in osteoporosis, NURS CLIN N, 36(3), 2001, pp. 481
Authors:
Adachi, JD
Saag, KG
Delmas, PD
Liberman, UA
Emkey, RD
Seeman, E
Lane, NE
Kaufman, JM
Poubelle, PEE
Hawkins, F
Correa-Rotter, R
Menkes, CJ
Rodriguez-Portales, JA
Schnitzer, TJ
Block, JA
Wing, J
McIlwain, HH
Westhovens, R
Brown, J
Melo-Gomes, JA
Gruber, BL
Yanover, MJ
Leite, MOR
Siminoski, KG
Nevitt, MC
Sharp, JT
Malice, MP
Dumortier, T
Czachur, M
Carofano, W
Daifotis, A
Citation: Jd. Adachi et al., Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids - A randomized, double-blind, placebo-controlled extension trial, ARTH RHEUM, 44(1), 2001, pp. 202-211
Authors:
Papaioannou, A
Ray, JG
Ferko, NC
Clarke, JAA
Campbell, G
Adachi, JD
Citation: A. Papaioannou et al., Estimation of creatinine clearance in elderly persons in long-term care facilities, AM J MED, 111(7), 2001, pp. 569-573
Authors:
Heckman, GA
Papaioannou, A
Adachi, JD
Denburg, JA
Citation: Ga. Heckman et al., Systemic lupus erythematosus presenting as subacute delirium in an 82-year-old woman, J AM GER SO, 49(4), 2001, pp. 458-461
Authors:
Hodsman, AB
Kisiel, M
Adachi, JD
Fraher, LJ
Watson, PH
Citation: Ab. Hodsman et al., Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis, BONE, 27(2), 2000, pp. 311-318
Authors:
Hanley, DA
Ioannidis, G
Adachi, JD
Citation: Da. Hanley et al., Etidronate therapy in the treatment and prevention of osteoporosis, J CLIN DENS, 3(1), 2000, pp. 79-95
Authors:
Haguenauer, D
Welch, V
Shea, B
Tugwell, P
Adachi, JD
Wells, G
Citation: D. Haguenauer et al., Fluoride for the treatment of postmenopausal osteoporotic fractures: A meta-analysis, OSTEOPOR IN, 11(9), 2000, pp. 727-738
Authors:
Crilly, RG
Sebaldt, RJ
Hodsman, AB
Adachi, JD
Brown, JP
Goldsmith, CH
Hanley, DA
Olszynski, WO
Ste-Marie, LG
Stephenson, GF
Citation: Rg. Crilly et al., Predicting subsequent bone density response to intermittent cyclical therapy with etidronate from initial density response in patients with osteoporosis, OSTEOPOR IN, 11(7), 2000, pp. 607-614
Authors:
Hopman, WM
Towheed, T
Anastassiades, T
Tenenhouse, A
Poliquin, S
Berger, C
Joseph, L
Brown, JP
Murray, TM
Adachi, JD
Hanley, DA
Papadimitropoulos, E
Citation: Wm. Hopman et al., Canadian normative data for the SF-36 health survey, CAN MED A J, 163(3), 2000, pp. 265-271
Authors:
Boulos, P
Adachi, JD
Citation: P. Boulos et Jd. Adachi, Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis, CLIN EXP RH, 18(5), 2000, pp. S79-S86
Authors:
Soucy, E
Bellamy, N
Adachi, JD
Pope, JE
Flynn, J
Sutton, E
Campbell, J
Citation: E. Soucy et al., A Canadian survey on the management of corticosteroid induced osteoporosisby rheumatologists, J RHEUMATOL, 27(6), 2000, pp. 1506-1512
Authors:
Adachi, JD
Roux, C
Pitt, PI
Cooper, C
Moniz, C
Dequeker, J
Ioannidis, G
Cawley, MID
Jenkins, EA
Walker-Bone, KE
Pack, S
Stephenson, GF
Laan, RF
Brown, J
Geusens, P
Citation: Jd. Adachi et al., A pooled data analysis on the use of intermittent cyclical etidronate therapy for the prevention and treatment of corticosteroid induced bone loss, J RHEUMATOL, 27(10), 2000, pp. 2424-2431
Authors:
Adachi, JD
Ioannidis, G
Citation: Jd. Adachi et G. Ioannidis, Glucocorticoid-induced osteoporosis, DRUG DEV R, 49(3), 2000, pp. 120-134
Authors:
Adachi, JD
Olszynski, WP
Hanley, DA
Hodsman, AB
Kendler, DL
Siminoski, KG
Brown, J
Cowden, EA
Goltzman, D
Ioannidis, G
Josse, RG
Ste-Marie, LG
Tenenhouse, AM
Davison, KS
Blocka, KLN
Pollock, AP
Sibley, J
Citation: Jd. Adachi et al., Management of corticosteroid-induced osteoporosis, SEM ARTH RH, 29(4), 2000, pp. 228-251
Authors:
Orwoll, E
Ettinger, M
Weiss, S
Miller, P
Kendler, D
Graham, J
Adami, S
Weber, K
Lorenc, R
Pietschmann, P
Vandormael, K
Lombardi, A
Adachi, JD
Bell, N
Body, JJ
Castro, A
Daifotis, A
Felsenberg, D
Gilchrist, N
Hoffman, A
Maricic, M
Rizzoli, R
Silverman, S
Valeriano, J
Citation: E. Orwoll et al., Alendronate for the treatment of osteoporosis in men, N ENG J MED, 343(9), 2000, pp. 604-610